Laboratorios Normon Sa
Laboratorios Normon is a privately held Spanish pharmaceutical company that develops, manufactures, and markets generic medicines, dental products, and OTC self-care pharmaceuticals, serving retail pharmacies, hospitals, dental practitioners, and international partners across 90+ countries from its Tres Cantos, Madrid manufacturing complex.
- Company typePrivate
- Founded1937
- HeadquartersTres Cantos, Spain
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What Laboratorios Normon Sa does
Laboratorios Normon, S.A. is a privately held Spanish pharmaceutical manufacturer founded in 1938 and headquartered in Tres Cantos, Madrid, where it operates one of the largest drug manufacturing complexes in Europe at over 100,000 m2. The company develops, manufactures, and markets generic medicines, dental products, and self-care (OTC) pharmaceuticals across five operating divisions: Generics, Hospitals, Dental, Self-care (Normon Contigo), and International. Its portfolio spans 340 active ingredients, 236 of which are commercialized as generics in over 1,200 presentations, 200+ dental SKUs led by the Ultracain anesthetic (launched 1992), and 188+ self-care products including the Bensania natural line. Normon was the pioneer of generic medicines in Spain, launching the first three generics and conducting the first bioequivalence study in 1997, and holds the #4 position in the total Spanish pharmaceutical market with 18.8% retail unit share, 19.1% hospital unit share, and 61.2% of the Spanish dental anesthetic market.
The business is monetized through prescription generic sales via retail pharmacies, direct hospital procurement, dental channel distribution, OTC self-care sales via the normoncontigo platform, and international revenues from 90+ countries generated through subsidiaries, licensing/supply agreements, and CMO services. Production scale reaches 4,966 million doses and 345+ million units annually, supported by 3,200+ professionals, dedicated capabilities in penicillin, cephalosporin, and high-containment/cytotoxic manufacturing, and a regulatory stack that includes EU GMP, US FDA approval (granted 2016 for sterile liquid vials), GLP, and six ISO certifications (9001, 14001, 13485, 20000, 27001, 27701). GTM motion is sales-led through healthcare professionals, pharmacies, hospitals, and dental practitioners domestically, paired with channel-partner and CMO-led internationalization abroad.
Recent strategic activity has emphasized consumer-health diversification (Bensania natural line 2024, new prescription packaging 2024), continued capacity expansion at the Tres Cantos campus, and FDA-enabled US market positioning, while remaining independently owned with no disclosed venture, private equity, or public-market backing and growing organically through reinvested profits.
Laboratorios Normon Sa firmographics
Firmographics- Name
- Laboratorios Normon Sa
- Legal name
- Laboratorios Normon, S.A.
- Website
- https://normon.com
- Company type
- Private
- Founded year
- 1937
- Operating status
- Operating
- Short description
- Laboratorios Normon is a privately held Spanish pharmaceutical company that develops, manufactures, and markets generic medicines, dental products, and OTC self-care pharmaceuticals, serving retail pharmacies, hospitals, dental practitioners, and international partners across 90+ countries from its Tres Cantos, Madrid manufacturing complex.
- Ownership category
- akta.pro rank
Laboratorios Normon Sa industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Generic Hospital & Institutional Products (HLAIABAL)
- akta.pro secondary industries
- Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH), Drug Product Fill-Finish & Aseptic Manufacturing Services (HLAAAKAB)
Keywords
Where Laboratorios Normon Sa is headquartered
LocationHeadquarters
- HQ city
- Tres Cantos
- HQ country
- Spain
- HQ region
- Europe
Offices3 records
Markets served
Laboratorios Normon Sa business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Prescription generic pharmaceuticals: Normon's core revenue stream from prescription generic medicines. The company is a pioneer in generic drugs in Spain (launched first generics in 1997) and holds leading market positions. The generics division covers 236 active ingredients in over 1,200 presentations across key therapeutic areas.
- Hospital pharmaceutical products: Supply of oral and parenteral pharmaceutical products to hospitals and clinics across Spain. Normon holds 19.1% hospital units market share in Spain and supplies 19% of total doses.
- Dental pharmaceutical products: Dental division products including Ultracain anesthetic (launched 1992), with Normon supplying anesthesia to one in two patients in Spain and holding 61.2% of the Spanish dental anesthetic market.
- Self-care and OTC products: Over-the-counter medicines and self-care products sold directly to consumers through pharmacy channels. Includes brands such as Bensania (natural products), Abrilia, Normomar, KitaPic, and Bucomed. Over 188 self-care products marketed.
- International exports and CMO services: International division managing exports to 90+ countries, with licensing and supply agreements, internationalization of Normon products, and Contract Manufacturing Organization (CMO) services for third parties.
- Professional services and training: Congress and training course management through Club Normonclass, including continuing education for healthcare professionals.
Go-to-market motion2 records
Distribution channels6 records
Marketing channels11 records
Laboratorios Normon Sa product offering
Product offeringCore offering
Laboratorios Normon is a Spanish pharmaceutical manufacturer that develops, produces, and markets generic prescription medicines, sterile hospital pharmaceutical products, dental specialty products (notably dental anesthetics including the Ultracain brand), and over-the-counter self-care products. The company operates multiple manufacturing facilities producing sterile injectables, oral solids, and topical formulations, and serves retail pharmacy, hospital, dental, and international healthcare channels across 90+ countries.
Product overview
Laboratorios Normon Sa operates as a pharmaceutical company with a diversified portfolio organized into five main divisions: Generics (pioneers in Spain since 1997 with 236+ active ingredients in 1,200+ presentations), Hospitals (oral and parenteral products in all Spanish clinics), Dental (200+ products including Ultracain anesthetic), Self-care/OTC (Normon Contigo platform with Bensania natural line and other brands), and International. The company also offers a digital prescription service (recetariobucomed.normon.com) for healthcare professionals. Products range from prescription pharmaceuticals to OTC self-care solutions and medical devices.
Differentiator
Problem solved
Functional benefit
Brands
- Bensania: Natural line of products made with natural ingredients, including royal jelly, probiotics, and CBD-based products for circulation, digestion, energy, stress, sleep, and respiratory health.
- Normon Contigo
- Club NormonClass
- Ultracain
- Abrilia
- Normomar
- KitaPic
- Bucomed
Products and services
- Generic Prescription Medicines (Division Genericos) Broad portfolio of generic prescription pharmaceutical products across multiple therapeutic areas, distributed through retail pharmacy wholesale, hospital pharmacy procurement, and international healthcare channels.
- Hospital Medicines (Division Hospitales) Sterile injectable and hospital-formulated pharmaceutical products supplied to hospital pharmacy procurement departments across public and private healthcare facilities, leveraging Normon's sterile manufacturing capabilities.
- Dental Pharmaceutical Products (Division Dental, incl. Ultracain) Specialty dental pharmaceutical portfolio anchored by the Ultracain brand of dental anesthetics (articaine-based), supplied to dental practitioners; Normon holds a leading share of the Spanish dental anesthetic market.
- Self-Care / OTC Consumer Products (Normon Contigo) Over-the-counter self-care product line covering common therapeutic categories such as pain relief and sleep aids, marketed under the Normon Contigo brand via retail pharmacies and own e-commerce channels.
- Pharmaceutical Contract Manufacturing (CMO) Services Third-party contract development and manufacturing services covering sterile liquids, oral solids, topical formulations, and cytotoxic high-containment production for external pharmaceutical clients, supported by Normon's FDA-approved manufacturing footprint.
- International Export and Licensing (Division Internacional) Distribution of Normon products to 90+ countries through export, partnership, agency, and licensing arrangements for healthcare systems and distributors outside Spain.
Quantifiable outcome
- Generic drugs save the Spanish National Health System (SNS) €1 billion per year.
- +5 more outcomes
Companies that use Laboratorios Normon Sa
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles5 records
Laboratorios Normon Sa technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Laboratorios Normon Sa partnerships and signals
Strategic signalScale indicators17 records
Recent moves10 records
Expansion highlights5 records
Laboratorios Normon Sa competitors and assessment
Company assessmentDirect peers
- Krka: Slovenian generic pharmaceutical manufacturer with strong CEE and Western European hospital penetration — comparable to Normon's hospital-channel focus, generics portfolio breadth, and export-driven growth.
- Faes Farma: Spanish pharmaceutical and OTC company with prescription, hospital, and consumer health divisions — directly comparable as a Spanish pharma across similar Rx/hospital/OTC channels.
- Almirall: Spanish pharmaceutical company focused on dermatology and specialty pharma with European commercial footprint — comparable as a Spanish-headquartered pharma with international commercial operations.
- Stada Arzneimittel: European-focused generics and consumer healthcare company headquartered in Germany — directly comparable to Normon's European generics, OTC/self-care, and licensing-driven international model.
- Laboratorios Rovi: Spanish specialty pharmaceutical company with hospital-channel focus, injectable manufacturing, and international growth — directly comparable as a Spanish-headquartered pharma with similar export ambitions.
- Zentiva: European generics manufacturer with strong presence in CEE, France, and Italy — comparable to Normon's European generics focus, hospital-channel emphasis, and multi-country distribution model.
Broad incumbents
- Sandoz (Novartis): European-headquartered global generics leader following its Novartis spin-off; comparable to Normon in European generic manufacturing, hospital-channel focus, and regulated-market expertise.
- Sanofi: Global broad pharmaceutical incumbent with significant European generics, OTC, and specialty operations — comparable in scale and European regulatory footprint though much broader than Normon's generics focus.
- Teva Pharmaceutical Industries: World's largest generic pharmaceutical manufacturer with a broad portfolio across therapeutic areas and CMO services — directly comparable to Normon in generics scale, FDA-approved manufacturing, and global distribution reach.
- Viatris (Mylan-Upjohn): Global generics and specialty pharma company with deep European and emerging-market presence — overlaps with Normon's generics portfolio, international footprint, and hospital channel.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Laboratorios Normon Sa social profiles
Digital presenceLaboratorios Normon Sa compliance and trust
Trust signalCompliance8 records
Laboratorios Normon Sa financial estimates
Financial estimateRevenue estimate
Valuation estimate
Laboratorios Normon Sa leadership team
Management profileNumber of profiles
Laboratorios Normon Sa funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Laboratorios Normon Sa M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Laboratorios Normon Sa
What does Laboratorios Normon Sa do?
Laboratorios Normon is a Spanish pharmaceutical manufacturer that develops, produces, and markets generic prescription medicines, sterile hospital pharmaceutical products, dental specialty products (notably dental anesthetics including the Ultracain brand), and over-the-counter self-care products. The company operates multiple manufacturing facilities producing sterile injectables, oral solids, and topical formulations, and serves retail pharmacy, hospital, dental, and international healthcare channels across 90+ countries.
Is Laboratorios Normon Sa a public or private company?
Laboratorios Normon Sa is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Laboratorios Normon Sa founded?
Laboratorios Normon Sa was founded in 1937.
Where is Laboratorios Normon Sa based?
Laboratorios Normon Sa is headquartered in Tres Cantos, Spain, in the Europe region.
How does Laboratorios Normon Sa make money?
Six revenue lines are on record. Prescription generic pharmaceuticals are the primary driver. The others are hospital pharmaceutical products, dental pharmaceutical products, self-care and OTC products, international exports and CMO services and professional services and training.
Who are Laboratorios Normon Sa's main competitors?
Direct peers on record are Krka, Faes Farma, Almirall, Stada Arzneimittel, Laboratorios Rovi and Zentiva. Broad incumbents are Sandoz (Novartis), Sanofi, Teva Pharmaceutical Industries and Viatris (Mylan-Upjohn).
Does Laboratorios Normon Sa have an API?
No public API is recorded for Laboratorios Normon Sa.
What industry is Laboratorios Normon Sa in?
Laboratorios Normon Sa's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products, with a secondary code of HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO. Its NAICS code is 325412 and its SIC code is 2834.